ALXA Financial Facts

Net loss attributable to Alexza common stockholders: -3.02M
General and administrative: 1.81M
See Full Income Statement

See Full Balance Sheet

Alexza Pharmaceuticals Inc. (ALXA) Earnings

  |   Expand Research on ALXA
Next EPS Date 5/5/16 *Est. EPS Growth Rate +57.1% *Last Qtr.
Average EPS % Beat Rate +40.0% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS -9.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/28/16 Q415 -$0.15N/A N/A $673K$1.45M N/A Details
11/5/15 Q315 -$0.27-$0.34 +$0.07$1.77M$1.6M N/A Details
8/6/15 Q215 -$0.63-$0.60 -$0.03N/A$1.49M N/A Details
5/6/15 Q115 -$0.02-$0.51 +$0.49$705K$3.36M N/A Details
3/9/15 Q414 -$0.35-$0.68 +$0.33$1.45B$1.3M N/A Details
8/7/14 Q214 -$0.34-$0.67 +$0.33$1.5M$2.24M N/A Details
11/6/13 Q313 -$0.72-$0.54 -$0.18$2.2M$1.98M N/A Details
8/8/13 Q213 -$0.21$0.09 -$0.30$40.84M$14.17M N/A Details